Home > Healthcare > Biotechnology > Biotechnology R&D > U.S. Bioreactors Market
U.S. Bioreactors Market Size
- Report ID: GMI10829
- Published Date: Aug 2024
- Report Format: PDF
U.S. Bioreactors Market Size
U.S. Bioreactors Market size was valued at around USD 3.8 billion in 2023 and is estimated to grow at 11% CAGR from 2024 to 2032. A bioreactor is a device or vessel that provides a controlled environment for the cultivation of organisms such as bacteria, yeast, or animal cells, or for enzymatic or chemical reactions involving these organisms. Bioreactors are utilized in various industries, including biotechnology, pharmaceuticals, and food production, to produce products such as proteins, vaccines, enzymes, biofuels, and other bio-based materials.
The growing demand for biopharmaceuticals in the U.S., along with advancements in bioreactor technology, is driving the market's expansion. Innovations like single-use bioreactors offer cost-effectiveness and process efficiency, attracting biopharmaceutical manufacturers who seek streamlined production processes. For example, in October 2021, Waters Corporation and Sartorius AG announced a strategic collaboration aimed at providing bioprocess experts with direct access to high-quality mass spectrometry (MS) data.
This initiative was designed to enhance the speed and accuracy of biopharmaceutical process development. The partnership involved integrating Waters Corporation's BioAccord LC-MS System with Sartorius AG's Ambr multi-parallel bioreactor systems. This integration delivered comprehensive mass spectral information on drug substances, related analytes, and cell culture media, significantly accelerating and improving the accuracy of tasks ranging from clone selection to bioprocess optimization.
Additionally, the rapid growth of the biotechnology sector, coupled with supportive government policies and stringent regulatory standards, further drives market growth. As a result, the market is experiencing a significant surge, stimulated by increased demand, technological advancements, and expanding sectors, establishing it as a critical component in the biopharmaceutical and biotechnology industries.
| Report Attribute | Details |
|---|---|
| Base Year: | 2023 |
| U.S. Bioreactors Market Size in 2023: | USD 3.8 Billion |
| Forecast Period: | 2024 to 2032 |
| Forecast Period 2024 to 2032 CAGR: | 11% |
| 2032 Value Projection: | USD 10.1 Billion |
| Historical Data for: | 2021 - 2023 |
| No. of Pages: | 100 |
| Tables, Charts & Figures: | 148 |
| Segments covered: | Product Type, Cell, Molecule, Usage, Material, Size, and End-use |
| Growth Drivers: |
|
| Pitfalls & Challenges: |
|
Frequently Asked Questions (FAQ) :
U.S. Bioreactors Market Scope
